Bi Sheng transferred to The General Manager of Merca East Korea Union Complaints Company Management...

On September 17, Mercadong Korea announced that Kevin Peters, General Manager of Mercadong Thailand, would become CEO of Mercadong Korea, effective November 1.
Kevin Peters' Chinese name is Bi Sheng, a former vice president and chief marketing officer of Merca East China, where he led both the Anesthesiology Division and the Vaccines Division, in addition to its marketing and strategy responsibilities.
Bisheng has nearly three decades of experience in pharmaceutical marketing and management, he graduated from the University of Newcastle in 1991, then joined the French company RonaPlank as a pharmaceutical representative, to put it other way, the pharmaceutical company entered the Chinese market relatively early, and then in 1999 and Germany Hest merged into Avant, in 2004, Avant joined Sanofi.
in 1997, Bisheng left RonaPlank to join Mercedon UK, where he served as Head of Merca East's UK Immunity Business, Head of Diversified Marketing for Mercadon's European Brand, and Head of Global Business for Merca East's Immunity Business.
since 2016, Bi sheng has been transferred to Merca East China as Vice President of China Market and Strategy of Merca East, and in May 2018, Bi Sheng has been transferred to Merca East Thailand as General Manager.
▌ Mercedong Korea's union complaint management mentioned last week that Mercedong Korea's union had told the media that it would negotiate compensation with Mercedon Korea, like Pfizer Korea, when Mercedon split Oganon and announced the transfer of employees to the new company.
Monday, South Korean media reported that the South Korean trade union in Meshadong violated the Personal Information Protection Act by collecting doctor information without the doctor's consent.
, the union's criticism has emerged since last year's launch of the Self-Assurance Program (SAP) by Mercer East Korea, which records doctors' meeting talks.
The program, which Big Mimi shared with small partners last year, stems from a 2018 program in which South Korean regulators allowed drug companies to keep records of all "financial subsidies" to doctors and pharmacists, so Mercedon Korea launched the program to check compliance with its medical representatives.
According to South Korean media reports at the time, The South Korean company will be 5 to 25 people of small product promotion will be randomly selected at 5%, through third-party agencies to monitor, should be equivalent to our domestic small will fly inspection.
project not only monitors Mercedon employees, but also records conversations between all doctors and Mercedon employees at product promotions, which also angers doctors.
after complaints from employees, the program conducted a call for employee recommendations in June and July 2019 and released new improvements on July 29.
, however, the South Korean trade union said management's so-called collection proposals were merely a showman and that under the current improvements, employees still had no choice but to maintain the original surveillance plan.
Turns out, the so-called improvement program offers two options, to maintain the original monitoring plan, to suspend the product promotion, the union believes that the elimination of product promotion will mean that pharmaceutical representatives lost the tools to promote drugs, which in effect forced pharmaceutical representatives to choose to continue to maintain the original monitoring plan, the company actually did not have the will to improve the situation.
, the conflict between workers and companies at merca East Korea is not what it is now, it has been going on for a year.
a year on, this time, the Mercer East Korea Union filed a formal complaint with management detailing examples of mesaton's invasion of doctors' privacy in the course of operations on sap and MSDonline websites, and Merced East Korea said it had worked with third-party law firms to review the allegations.
The union also mentioned more unreasonable points, such as the expansion of the self-assurance program from meetings with more than five doctors to meetings of two or more doctors, notifying medical representatives and doctors 45 minutes before the meeting, recording meetings with medical examiners, and requiring doctors to keep check-in forms within the company and forcing employees to upload check-in forms on websites and reimbursements.
According to the union, the company collected medical doctors' meeting signature information without their consent, and third-party flight inspectors recorded exchanges and filmed check-in forms, which could be illegal, and the union has consulted the Korea Information Security Administration (KISA) about the legality.
According to feedback from the Korea Information Security Administration, it is not illegal for a pharmaceutical company to refer to a photo of the personal information in the check-in form in a third-party agreement, but a third-party company must give notice in public written form, otherwise it is illegal.
In addition, the union also pointed out that the terms of msDonline's registration were also an invasion of privacy, and that the service agreement, which also included privacy collection provisions, was a "coercive" act that failed to meet its obligation to specify and inform and was not explicitly authorized by a doctor.
.